How to prepare an Isosorbide Dinitrate (ISDN) drip?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

How to Prepare an Isosorbide Dinitrate (ISDN) Drip

ISDN is not available for intravenous use in the United States—only nitroglycerin is FDA-approved for IV administration. 1

Critical Point: ISDN Cannot Be Given as an IV Drip

  • Nitroglycerin is the only nitrate formulation available for intravenous use in the United States, as stated by the ACC/AHA guidelines 1
  • ISDN is available only in oral formulations (immediate-release tablets, sustained-release tablets, and sublingual forms) 1
  • The half-life of ISDN ranges from 40 to 90 minutes, and it undergoes extensive hepatic metabolism to active metabolites 1

Alternative: Nitroglycerin IV Infusion

If you need intravenous nitrate therapy, you must use nitroglycerin instead of ISDN:

Nitroglycerin IV Preparation

  • Nitroglycerin has a very short half-life of only several minutes, making it suitable for IV titration 1
  • Standard preparation involves diluting nitroglycerin in D5W or normal saline using non-PVC tubing (as nitroglycerin absorbs into PVC)
  • Typical starting dose: 5-10 mcg/min, titrated upward by 5-10 mcg/min every 3-5 minutes based on blood pressure and symptom response 1

Critical Monitoring Requirements

  • Carefully monitor blood pressure to avoid inadvertent systemic hypotension, which can cause reflex tachycardia and worsen myocardial ischemia 1
  • Exercise extreme caution in patients with inferior wall MI due to frequent association with right ventricular infarction—these patients depend on adequate RV preload and can experience profound hypotension 1, 2
  • If hypotension occurs, manage with leg elevation, rapid fluid administration, and atropine if severe 1

Oral ISDN Dosing (If Appropriate)

If oral therapy is acceptable for your clinical scenario:

Standard Oral ISDN Regimen

  • Starting dose: 20 mg three times daily 1
  • Target dose: 40 mg three times daily after 2-4 weeks if tolerated 1
  • When combined with hydralazine for heart failure (particularly in African American patients): start with hydralazine 37.5 mg + ISDN 20 mg three times daily, titrating to hydralazine 75 mg + ISDN 40 mg three times daily 1, 2

Essential Tolerance Prevention

  • Provide a nitrate-free interval of at least 10-14 hours daily to prevent tolerance development 1, 3, 2
  • Tolerance typically develops after 24 hours of continuous therapy 2, 4
  • The nitrate-free interval can be achieved by timing doses appropriately (e.g., 8 AM, 1 PM, 6 PM, with overnight nitrate-free period) 1

Common Pitfalls to Avoid

  • Never use ISDN within 24 hours of sildenafil or 48 hours of tadalafil due to risk of profound hypotension 2
  • Do not increase dose if symptomatic hypotension occurs 1
  • Watch for drug-induced lupus-like syndrome (arthralgia, joint swelling, pericarditis, rash, fever)—if suspected, check ANA and discontinue 1
  • Headaches are the most common side effect but often improve with continued use 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Isosorbide Dinitrate Management for Angina Pectoris

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Isosorbide Mononitrate Mechanism and Side Effects

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.